aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 0.00 (-2.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Amortization of Deferred Charges (2014 - 2017)

Updated

Analysis

aTYR PHARMA (ATYR) Amortization of Deferred Charges (2014 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 aTYR PHARMA 16.22 Mn -276.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -37,000.00
Dec 31, 2016 43,000.00
Sep 30, 2016 33,000.00
Jun 30, 2016 43,000.00
Mar 31, 2016 54,000.00
Dec 31, 2015 59,000.00
Sep 30, 2015 70,000.00
Jun 30, 2015 40,000.00
Mar 31, 2015 128,000.00
Dec 31, 2014 131,000.00
Sep 30, 2014 140,000.00
Jun 30, 2014 85,000.00
Mar 31, 2014 70,000.00
API Access

aTYR PHARMA Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ATYR&period=max&api_key=YOUR_API_KEY